Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: robert heisman who wrote (7236)	5/5/1998 8:43:00 PM
From: Robert M. Winn	Read Replies (3) \| Respond to of 8116

My personal gut feeling is that all cancer stocks will show good revenues over the next couple of years. Given the hope of a magic bullet being available in two to five years, both patients and doctors are going to be more aggressive in cancer treatments in order to survive until a cure is found. The study that showed that Quadrament added just one more year to the life of a breast cancer patient means that Quad is a lot more important if someone is to survive until the cure.